A detailed history of Advisor Partners Ii, LLC transactions in Seagen Inc. stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 1,596 shares of SGEN stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,596
Previous 1,242 28.5%
Holding current value
$0
Previous $239,000 41.42%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$191.51 - $216.16 $67,794 - $76,520
354 Added 28.5%
1,596 $338,000
Q2 2023

Aug 10, 2023

BUY
$187.64 - $206.25 $35,839 - $39,393
191 Added 18.17%
1,242 $239,000
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $134,097 - $213,437
1,051 New
1,051 $212,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.